-
EP3284741
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3284741
| EP3284741 - ANTIVIRAL COMPOUNDS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.06.2020 Database last updated on 11.04.2026 | |
| Former | Examination is in progress Status updated on 01.06.2019 | ||
| Former | Request for examination was made Status updated on 19.01.2018 | Most recent event Tooltip | 26.06.2020 | Application deemed to be withdrawn | published on 29.07.2020 [2020/31] | Applicant(s) | For all designated states Gilead Pharmasset LLC 333 Lakeside Drive Foster City, CA 94404 / US | [2018/08] | Inventor(s) | 01 /
BACON, Elizabeth M. c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 02 /
COTTELL, Jeromy J. c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 03 /
KATANA, Ashley Anne c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 04 /
KATO, Darryl c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 05 /
KRYGOWSKI, Evan S. c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 06 /
LINK, John O. c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 07 /
TAYLOR, James c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 08 /
TRAN, Chinh Viet c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 09 /
TREJO MARTIN, Teresa Alejandra c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 10 /
YANG, Zheng-Yu c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | 11 /
ZIPFEL, Sheila c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404 / US | [2018/08] | Representative(s) | Fairbairn, Angus Chisholm Marks & Clerk LLP 15 Fetter Lane London EC4A 1BW / GB | [N/P] |
| Former [2018/08] | Fairbairn, Angus Chisholm Marks & Clerk LLP 90 Long Acre London WC2E 9RA / GB | Application number, filing date | 17169675.0 | 16.11.2011 | [2018/08] | Priority number, date | US20100414818P | 17.11.2010 Original published format: US 414818 P | US201161504924P | 06.07.2011 Original published format: US 201161504924 P | [2018/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3284741 | Date: | 21.02.2018 | Language: | EN | [2018/08] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 07.12.2017 | Classification | IPC: | C07D403/14, C07D405/14, C07D417/14, C07D471/08, C07D491/10, C07D493/04, C07D495/04, C07D513/04, A61K31/4178, A61K31/4184, A61K31/4188, A61P31/12, A61K45/06 | [2018/08] | CPC: |
C07D403/14 (EP,KR,US);
A61K31/4178 (EP,KR,US);
A61K31/4184 (EP,US);
A61K31/4188 (EP,KR,US);
A61K31/5377 (EP,KR,US);
A61K45/06 (EP,KR,US);
A61P1/16 (EP);
A61P31/00 (EP);
A61P31/12 (EP,KR);
A61P31/14 (EP);
A61P31/18 (EP);
A61P43/00 (EP);
C07D405/14 (EP,KR,US);
C07D417/14 (EP,US);
C07D471/08 (EP,US);
C07D491/10 (EP,US);
C07D491/107 (EP,US);
C07D491/113 (EP,US);
C07D493/04 (EP,US);
C07D495/04 (EP,US);
C07D513/04 (EP,US);
A61K2300/00 (KR)
(-)
| C-Set: |
A61K31/4178, A61K2300/00 (EP,US);
A61K31/4184, A61K2300/00 (US,EP);
A61K31/4188, A61K2300/00 (US,EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/08] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | ANTIVIRALE VERBINDUNGEN | [2018/08] | English: | ANTIVIRAL COMPOUNDS | [2018/08] | French: | COMPOSÉS ANTIVIRAUX | [2018/08] | Examination procedure | 05.05.2017 | Examination requested [2018/08] | 05.05.2017 | Date on which the examining division has become responsible | 12.12.2018 | Amendment by applicant (claims and/or description) | 05.06.2019 | Despatch of a communication from the examining division (Time limit: M06) | 17.12.2019 | Application deemed to be withdrawn, date of legal effect [2020/31] | 20.01.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/31] | Parent application(s) Tooltip | EP11791700.5 / EP2640719 | Divisional application(s) | EP19215845.9 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 12.12.2018 | Request for further processing filed | 12.12.2018 | Full payment received (date of receipt of payment) Request granted | 02.01.2019 | Decision despatched | Fees paid | Renewal fee | 05.05.2017 | Renewal fee patent year 03 | 05.05.2017 | Renewal fee patent year 04 | 05.05.2017 | Renewal fee patent year 05 | 05.05.2017 | Renewal fee patent year 06 | 27.11.2017 | Renewal fee patent year 07 | 27.11.2018 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.11.2019 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IP] WO2011075439 (BRISTOL MYERS SQUIBB CO et al.) | [I] WO2008021927 (BRISTOL MYERS SQUIBB CO et al.) | [I] WO2008021928 (BRISTOL MYERS SQUIBB CO et al.) | [I] WO2008021936 (BRISTOL MYERS SQUIBB CO et al.) | [I] WO2009102318 (BRISTOL MYERS SQUIBB CO et al.) | [I] WO2009102325 (BRISTOL MYERS SQUIBB CO et al.) | [I] WO2010062821 (GLAXOSMITHKLINE LLC et al.) | [IP] WO2010132601 (GILEAD SCIENCES INC et al.) | [IP] WO2010138368 (BRISTOL MYERS SQUIBB CO et al.) | [IP] WO2011028596 (GLAXOSMITHKLINE LLC et al.) | [E] WO2011146401 (INTERMUNE INC et al.) | [E] WO2012027712 (RFS PHARMA LLC et al.) | [E] WO2012048421 (BOEHRINGER INGELHEIM INT et al.) | [E] WO2012087976 (INTERMUNE INC et al.) | by applicant | US4816570 | US4968788 | US5663159 | US5792756 | WO9119721 | WO2006020276 | WO9615111 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 54, September 2010 (2010-09-01), pages 3641 - 3650 | PAQUETTE, LEO A.: "Principles of Modern Heterocyclic Chemistry", 1968, W.A. BENJAMIN, NEW YORK | "The Chemistry of Heterocyclic Compounds, A Series of Monographs", vol. 13, 14,, 1950, JOHN WILEY & SONS, NEW YORK | J. AM. CHERN. SOC. | "McGraw-Hill Dictionary of Chemical Terms", 1984, MCGRAW-HILL BOOK COMPANY, NEW YORK | ELIEL, E.; WILEN, S.: "Stereochemistry of Organic Compounds", 1994, JOHN WILEY & SONS, INC., NEW YORK | BUNDGAARD, HANS: "A Textbook of Drug Design and Development", 1991, HARWOOD ACADEMIC PUBLISHERS, article "Design and Application of Prodrugs", pages: 113 - 191 | FARQUHAR ET AL., J. PHARM. SCI., vol. 72, 1983, pages 324 | DE LOMBAERT ET AL., J. MED. CHEM., vol. 37, 1994, pages 498 | KHAMNEI; TORRENCE, J. MED. CHEM., vol. 39, 1996, pages 4109 - 4115 | MITCHELL ET AL., J. CHEM. SOC. PERKIN TRANS., vol. 112, 1992, pages 345 | PUECH ET AL., ANTIVIRAL RES., vol. 22, 1993, pages 155 - 174 | BENZARIA ET AL., J. MED. CHEM., vol. 39, 1996, pages 4958 | THEODORA W. GREENE: "Protective Groups in Organic Chemistry", 1991, JOHN WILEY & SONS, INC., NEW YORK | THEODORA W. GREENE: "Protective Groups in Organic Synthesis", 1991, JOHN WILEY & SONS, INC., NEW YORK | KOCIENSKI, PHILIP J.: "Protecting Groups", 1994, GEORG THIEME VERLAG STUTTGART, NEW YORK | "PROTECTING GROUPS", 1994, article "Chapter 1", pages: 1 - 20 | "PROTECTING GROUPS", 1994, article "Chapter 2", pages: 21 - 94 | "PROTECTING GROUPS", 1994, article CHAPTER 3, pages: 95 - 117 | "PROTECTING GROUPS", 1994, article CHAPTER 4, pages: 118 - 154 | "PROTECTING GROUPS", 1994, article "Chapter 5", pages: 155 - 184 | "Handbook of Pharmaceutical Excipients", 1986 | "Remington's Pharmaceutical Sciences", MACK PUBLISHING CO., EASTON, PA | IAN T. HARRISON; SHUYEN HARRISON: "Compendium of Organic Synthetic Methods", vol. 1, 1971, JOHN WILEY & SONS, NEW YORK | IAN T. HARRISON; SHUYEN HARRISON: "COMPENDIUM OF ORGANIC SYNTHETIC METHODS", vol. 2, 1974, JOHN WILEY & SONS, NEW YORK | LOUIS S. HEGEDUS; LEROY WADE: "COMPENDIUM OF ORGANIC SYNTHETIC METHODS", vol. 3, 1977 | LEROY G. WADE, JR.: "COMPENDIUM OF ORGANIC SYNTHETIC METHODS", vol. 4, 1980 | LEROY G. WADE, JR.: "COMPENDIUM OF ORGANIC SYNTHETIC METHODS", vol. 5, 1984 | MICHAEL B. SMITH: "COMPENDIUM OF ORGANIC SYNTHETIC METHODS", vol. 6 | MARCH, J.: "Advanced Organic Chemistry", 1985, JOHN WILEY & SONS, NEW YORK | "mprehensive Organic Synthesis. Selectivitv, Strategy & Efficiency in Modern Organic Chemistry", vol. 9, 1993, PERGAMON PRESS, NEW YORK | "Stereochemistry of Carbon Compounds", 1962 | LOCHMULLER, C. H., J. CHROMATOGR., vol. 113, no. 3, 1975, pages 283 - 302 | ELIEL, E.; WILEN, S.: "Stereochemistry of Organic Compounds", 1994, JOHN WILEY & SONS, INC., pages: 322 | JACOB III., J. ORG. CHEM., vol. 47, 1982, pages 4165 | "Chiral Liquid Chromatography", 1989, CHAPMAN AND HALL, NEW YORK | OKAMOTO, J. OF CHROMATOGR., vol. 513, 1990, pages 375 - 378 | WUTS, P. G. M.; GREENE, T.: "Protective Groups in Organic Synthesis", 2007, JOHN WILEY & SONS, INC.: HOBOKEN, NEW JERSEY |